TY - JOUR
T1 - Electroanatomical characteristics of idiopathic left ventricular tachycardia and optimal ablation target during sinus rhythm
T2 - Significance of preferential conduction through purkinje fibers
AU - Park, Junbeom
AU - Kim, Young Hoon
AU - Hwang, Chun
AU - Pak, Hui Nam
PY - 2012/3
Y1 - 2012/3
N2 - Purpose: We hypothesized that Purkinje potential and their preferential conduction to the left ventricle (LV) posteroseptum during sinus rhythm (SR) are part of reentrant circuits of idiopathic left ventricular tachycardia (ILVT) and reentry anchors to papillary muscle. Materials and Methods: In 14 patients with ILVT (11 men, mean age 31.5±11.1 years), we compared Purkinje potential and preferential conduction during SR with VT by non-contact mapping (NCM). If clear Purkinje potential (SR) was observed in the LV posteroseptum and the earliest activation site (EA) of preferential conduction at SR (EA SR) was well matched with that of VT (EA VT), EA SR was targeted for radiofrequency catheter ablation (RFCA). Also, the anatomical locations of successful ablation sites were evaluated by echocardiogra-phy in five additional patients. Results: 1) All induced VTs exhibited clear Purkinje potential (VT) and preferential conduction in the LV posteroseptum. The Purkinje potential (VT) and EA VT was within 5.8±8.2 mm of EA SR. However, the breakout sites of VT were separated by 30.2±12.6 mm from EA VT to the apical side. 2) Purkinje potential(SR) demonstrated a reversed polarity to Purkinje potential(VT), and the interval of Purkinje potential (SR)-QRS was longer than the interval of Purkinje potential (VT)-QRS (p<0.02) 3) RFCA targeting EA SR eliminated VT in all patients without recurrence within 23.3±7.5 months, and the successful ablation site was discovered at the base of papillary muscle in the five additional (100%) patients. Conclusion: NCM-guided localization of EA SR with Purkinje potential (SR) matches well with EA VT with Purkinje potential (VT) and provides an effective target for RFCA, potentially at the base of papillary muscle in patients with ILVT.
AB - Purpose: We hypothesized that Purkinje potential and their preferential conduction to the left ventricle (LV) posteroseptum during sinus rhythm (SR) are part of reentrant circuits of idiopathic left ventricular tachycardia (ILVT) and reentry anchors to papillary muscle. Materials and Methods: In 14 patients with ILVT (11 men, mean age 31.5±11.1 years), we compared Purkinje potential and preferential conduction during SR with VT by non-contact mapping (NCM). If clear Purkinje potential (SR) was observed in the LV posteroseptum and the earliest activation site (EA) of preferential conduction at SR (EA SR) was well matched with that of VT (EA VT), EA SR was targeted for radiofrequency catheter ablation (RFCA). Also, the anatomical locations of successful ablation sites were evaluated by echocardiogra-phy in five additional patients. Results: 1) All induced VTs exhibited clear Purkinje potential (VT) and preferential conduction in the LV posteroseptum. The Purkinje potential (VT) and EA VT was within 5.8±8.2 mm of EA SR. However, the breakout sites of VT were separated by 30.2±12.6 mm from EA VT to the apical side. 2) Purkinje potential(SR) demonstrated a reversed polarity to Purkinje potential(VT), and the interval of Purkinje potential (SR)-QRS was longer than the interval of Purkinje potential (VT)-QRS (p<0.02) 3) RFCA targeting EA SR eliminated VT in all patients without recurrence within 23.3±7.5 months, and the successful ablation site was discovered at the base of papillary muscle in the five additional (100%) patients. Conclusion: NCM-guided localization of EA SR with Purkinje potential (SR) matches well with EA VT with Purkinje potential (VT) and provides an effective target for RFCA, potentially at the base of papillary muscle in patients with ILVT.
KW - Catheter ablation
KW - Idiopathic left ventricular tachycardia
KW - Non-contact map
KW - Purkinje
UR - http://www.scopus.com/inward/record.url?scp=84863153172&partnerID=8YFLogxK
U2 - 10.3349/ymj.2012.53.2.279
DO - 10.3349/ymj.2012.53.2.279
M3 - Article
C2 - 22318814
AN - SCOPUS:84863153172
SN - 0513-5796
VL - 53
SP - 279
EP - 288
JO - Yonsei Medical Journal
JF - Yonsei Medical Journal
IS - 2
ER -